NCT07331753

Brief Summary

The outcomes of fat grafting combined with latissimus dorsi muscle flap for delayed breast reconstruction after mastectomy

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
18mo left

Started Nov 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Nov 2025Nov 2027

Study Start

First participant enrolled

November 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 29, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

January 12, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 29, 2025

Last Update Submit

December 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Wound infection or dehesiens

    2 weeks

Study Arms (1)

Female patients with breast cancer undergoing mastectomy

ACTIVE COMPARATOR

Delayed breast reconstruction after breast cancer mastectomy

Procedure: Fat grafting combined with latissimus dorsi muscle flap

Interventions

Fat grafting combined with latissimus dorsi muscle flap for delayed breast reconstruction

Female patients with breast cancer undergoing mastectomy

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • female patient indicated for skin sparying mastectomy

You may not qualify if:

  • female patients with stage 4 breast cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag university hospital

Sohag, Sohag Governorate, Egypt

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer of plastic surgery sohag university

Study Record Dates

First Submitted

December 29, 2025

First Posted

January 12, 2026

Study Start

November 1, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2027

Last Updated

January 12, 2026

Record last verified: 2025-12

Locations